Gustav Gram the Chief Executive of Pila Pharma

episode

Breakfast Business with Joe Lynam not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Breakfast Business with Joe Lynam

K-shaped economy 6 min · 23 Dec 2025

Medtech firm secures funding to support its push for US regulatory clearance 8 min · 23 Dec 2025

Tuesday's business headlines 3 min · 23 Dec 2025

Volatile Geopolitics the New Norm 7 min · 22 Dec 2025

Monday's business headlines 9 min · 22 Dec 2025

A positive picture for the domestic economy 7 min · 19 Dec 2025

All episodes from Breakfast Business with Joe Lynam →

Report any issue

Source

Recorded09 Apr 2025

Publisherrss.podplaystudio.com

Handlerec:9174291

Show notes

Danish company Novo Nordisk came up with a revolutionary weight loss drug called Wegovy and Ozempic. Its rival Eli Lilly has Mounjaro and Pfizer is looking at developing one too. Now another Scandinavian pharmaceutical group Pila Pharma thinks it may have found another weight loss pill too. Speaking to Joe this morning was Gustav Gram, the Chief Executive of Pila Pharma.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in